Detalhe da pesquisa
1.
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9.
J Biol Chem
; 287(14): 11090-7, 2012 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294692
2.
Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.
J Pharmacol Exp Ther
; 340(2): 228-36, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22019884
3.
Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Eur Neuropsychopharmacol
; 19(7): 466-75, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19223157